Schedule 13G ownership disclosure
Bicara Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 055477103
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Vestal Point Capital, LP
Shares: 3,575,000.00 · Class: 6.5%
- Ryan Wilder
Shares: 3,575,000.00 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-26-001089
- Form type
- SCHEDULE 13G/A
- Filer
- Bicara Therapeutics Inc.
- CIK
- CIK 2023658
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership